1702P Updated Results of Phase II Study of Cabozantinib (cabo) with Nivolumab (nivo) and Ipilimumab (ipi) in Advanced Renal Cell Carcinoma with Divergent Histologies (Rccdh)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined